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Abstract
Background: Periodontitis is an inflammatory disease caused by pathogenic microorganisms, such as Porphyromonas
gingivalis, and characterized by the destruction of the periodontium. Obese individuals have an increased risk for
periodontitis and show decreased serum levels of adiponectin. This in-vitro study was established to examine whether
adiponectin modulates critical effects of lipopolysaccharide (LPS) from P. gingivalis on oral epithelial cells (OECs).
Methodology/Principal Findings: The presence of adiponectin and its receptors in human gingival tissue samples and
OECs was analyzed by immunohistochemistry and PCR. Furthermore, OECs were treated with LPS and/or adiponectin for up
to 72 h, and the gene expression and protein synthesis of pro- and anti-inflammatory mediators, matrix metalloproteinases
(MMPs) and growth factors were analyzed by real-time PCR and ELISA. Additionally, cell proliferation, differentiation and in-
vitro wound healing were studied. The nuclear translocation of NFkB was investigated by immunofluorescence. Gingival
tissue sections showed a strong synthesis of adiponectin and its receptors in the epithelial layer. In cell cultures, LPS induced
a significant up-regulation of interleukin (IL) 1b, IL6, IL8, MMP1 and MMP3. Adiponectin abrogated significantly the
stimulatory effects of LPS on these molecules. Similarly, adiponectin inhibited significantly the LPS-induced decrease in cell
viability and increase in cell proliferation and differentiation. Adiponectin led to a time-dependent induction of the anti-
inflammatory mediators IL10 and heme oxygenase 1, and blocked the LPS-stimulated NFkB nuclear translocation.
Conclusions/Significance: Adiponectin may counteract critical actions of P. gingivalis on oral epithelial cells. Low levels of
adiponectin, as observed in obese individuals, may increase the risk for periodontal inflammation and destruction.
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Introduction
Periodontitis is a chronic inflammatory disease and characterized
by the progressive destruction of the tooth-supporting tissues, i.e.
periodontium. The disease is caused by pathogenic bacteria
embedded in a biofilm on the tooth surface and leads to epithelial
proliferation in combination with periodontal pocket formation,
increased tooth mobility and even toothloss[1]. Based on data from
the National Health and Nutrition Examination Survey (NHANES)
III, which assessed the health and nutritional status in the United
States, it is estimated that half of the US population aged over 30
years suffers from periodontitis [2]. Periodontitis has a significant
negative impact on a wide range of physical, psychological and
social aspects of quality of life in affected individuals [3,4].
Furthermore, periodontal infections are associated with cardiovas-
cular diseases, diabetes mellitus, arthritis, preterm low birth weight
and other systemic diseases and conditions [5].
Although a variety of microorganisms have been associated with
periodontitis, Porphyromonas gingivalis represents one of the main
etiologic agents in the initiation and progression of periodontal
diseases, and is found more frequently and in higher numbers at
sites of periodontal inflammation [6]. P. gingivalis is characterized
by a great number of virulence factors with proteases, such as
gingipains, being the most important ones [7]. Another key
virulence factor of P. gingivalis is lipopolysaccharide (LPS) [8]. LPS
is the major macromolecule on the outer surface of gram-negative
microorganisms and binds to a Toll-like receptor (TLR) 4–MD-2–
CD14 protein complex. However, LPS of P. gingivalis is different
from those of enterobacteria in that LPS of P. gingivalis also signals
through TLR2 and is less potent in inducing an inflammatory
reaction [8–10]. The oral epithelium is the first physical barrier,
which periodontopathogenic bacteria encounter [6]. By the release
of pro-inflammatory and chemotactic cytokines, matrix-degrading
enzymes and prostaglandins, oral epithelial cells, which express
TLRs, function as non-professional inflammatory cells and help
professional cells of the innate and adaptive immune system to
clear the bacterial infection [11–13]. Therefore, oral epithelial cells
can actively participate in periodontal inflammation. However, a
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If the inflammatory response is exaggerated, irreversible loss of
periodontal tissues occurs [14,15]. Levels of pro-inflammatory
cytokines, such as interleukin (IL) 1b, IL6, and IL8, which
promote recruitment and activation of professional inflammatory
cells, are increased at inflamed sites [16–18]. Although anti-
inflammatory mediators, such as IL10, antagonize the pro-
inflammatory activities, the balance between pro- and anti-
inflammatory mediators is shifted towards inflammation [14,15].
In response to pathogenic microorganisms and inflammatory
mediators, resident cells and infiltrated inflammatory cells of the
periodontium release enzymes, such as matrix metalloproteinases
(MMPs). MMPs can cleave all components of the extracellular
matrix and, additionally, activate, deactivate, or modify non-
matrix bioactive molecules [19]. In periodontitis, the balance
between matrix synthesis and degradation is disrupted and shifted
towards periodontal tissue destruction [19].
As mentioned above, periodontitis has been shown to affect
systemic health. Conversily, systemic diseases, such as diabetes
mellitus, can also increase the risk of periodontitis. Recent meta-
analyses have revealed that obesity is also significantly associated
with periodontitis, and it has been suggested that adipokines, such
as adiponectin, which are cytokines released from the adipose
tissue, might be a critical pathomechanistic link in this association
[20–22]. Adipokines not only regulate food intake and energy
expenditure, but also immune, inflammatory and wound healing
processes. For example, adiponectin plays an anti-inflammatory
role in the pathophysiology of several chronic inflammatory
diseases [23,24]. Heme oxygenase 1 (HMOX1) has recently been
identified as an important downstream mediator for the anti-
inflammatory actions of adiponectin in primary cultures of
Kupffer cells [25]. HMOX1 catabolizes heme into carbon
monoxide, biliverdin and free iron, which then exert the anti-
inflammatory, anti-apoptotic and anti-proliferative effects of
HMOX1 [26]. Besides its effects on inflammatory mediators,
adiponectin has also been shown to be involved in cell
proliferation and differentiation [27]. A common marker of
keratinocyte differentiation is involucrin, which first appears in the
cytoplasm of differentiating cells in the stratum spinosum and is
then cross-linked to membrane proteins in the stratum granulosum
by the action of transglutaminase enzymes, which provides
structural support to the cells [28–30].
Since serum levels of adiponectin have been shown to be
negatively correlated with overweight and obesity, the beneficial
effects of adiponectin are significantly reduced in overweight and
obese individuals [31]. Whether adiponectin regulates the function
of periodontal cells and inflammatory processes in periodontitis is
as yet unknown. This in-vitro study was established to examine
whether adiponectin inhibits the response of oral epithelial cells to
LPS from P. gingivalis and, thereby, to test the hypothesis that
decreased levels of adiponectin may confer an increased risk of
periodontal destruction.
Materials and Methods
Isolation and culture of human oral epithelial cells
Healthy gingival tissues were obtained from six donors, who
underwent tooth extraction and/or dentoalveolar surgery. Written
informed parental consent and approval of the Ethics Committee
of the University of Bonn were obtained. The gingival specimens
were washed twice with phosphate buffered saline (PBS; PAA
Laboratories, Co ¨lbe, Germany) supplemented with 1% antibiotic
and antimycotic solution (PAA Laboratories) and subsequently
digested with collagenase 2 solution (PAA Laboratories) at 37uC
for 2.5 h. Afterwards, the epithelium was mechanically separated
from the underlying connective tissue layer with sterile forceps. In
order to obtain a single cell suspension, the epithelium was then
dissociated with 0.05% trypsin in 0.02% EDTA solution (PAA
Laboratories) at 37uC for 15 min. After centrifugation, epithelial
cells were resuspended in serum-free keratinocyte growth medium
(KGM2; Promocell, Heidelberg, Germany) supplemented with
1% antibiotic and antimycotic solution, and grown at 37uCi na
humidified atmosphere of 5% CO2. Cells were used at passage
three and medium was changed every other day. For evaluation of
cell viability, epithelial cells were stained with trypan blue solution
(Sigma-Aldrich, Munich, Germany) and, subsequently, live and
dead cells were counted.
Cell stimulation
Cells were stimulated with ultrapure LPS from P. gingivalis
(2 mg/ml; Cayla-InvivoGen, Toulouse, France) and/or recombi-
nant human full-length adiponectin (1 mg/ml; R&D Systems,
Wiesbaden, Germany) for up to 72 h. The concentrations applied
were based on the results from other studies to ensure that data are
comparable [11,13,32]. Furthermore, pre-experiments showed
that these concentrations had a significant stimulatory effect on
pro- and anti-inflammatory cytokines and, therefore, allowed to
examine the interactions of LPS and adiponectin on epithelial cells
(data not shown).
Reverse transcription-PCR
Total RNA was isolated using the RNeasy Protect Mini Kit
(Qiagen, Hilden, Germany) and quantified using the Nano-
DropHND-1000 Spectrophotometer (NanoDrop Technologies,
Wilmington, DE, USA). A total of 1 mg of RNA was reversely
transcribed using iScript
TM Select cDNA Synthesis Kit (Bio-Rad
Laboratories, Munich, Germany) with oligo(dT)-primers accord-
ing to the manufacturer’s protocol. The gene expression of
adiponectin and its receptors AdipoR1 and AdipoR2, IL1b, IL6,
IL8, IL10, heme oxygenase 1 (HMOX1), MMP1, MMP3,
transforming growth factor (TGF) b1, keratinocyte growth factor
(KGF), and involucrin was detected by real-time PCR using the
iCycler iQ detection system (Bio-Rad Laboratories), SYBR Green
(Bio-Rad Laboratories), and specific primers (Metabion, Martins-
ried, Germany). Primer sequences, annealing temperatures and
efficiencies are presented in Table 1. Real-time PCR was
performed by adding 50 ng cDNA to a master mix containing
primers and iQ
TM SYBRH Green Supermix (Bio-Rad Laborato-
ries). Cloned PCR-products derived from the specific primers
served as positive controls, whereas water was used as negative
control. PCR conditions were defined as follows: 5 min preceding
denaturation step at 95uC was succeeded by 50 cycles of 15 s at
95uC, 30 s at annealing temperatures specific for the primers, and
30 s at 72uC for elongation. Relative differential gene expression
was calculated using the method described by Pfaffl [33] with b-
actin serving as house-keeping gene. Additionally, the PCR
products for adiponectin, AdipoR1 and AdipoR2 were visualized
by 2% agarose gel electrophoresis and ethidium bromide staining.
ELISA
The concentrations of IL1b, IL8 and MMP1 in culture
supernatants at 24 h and 72 h were analyzed by a commercially
available enzyme-linked immunoassay (ELISA) kit (RayBiotech,
Norcross, USA) according to the manufacturer’s instructions. The
absorbance was measured with a microplate reader (Bio-Rad
Laboratories) at 450 nm. The data were normalized by the cell
number, which was measured with an automatic cell counter
(Moelab, Hilden, Germany).
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The epithelial cell proliferation was determined by using the
PromoKine XTT Cell Proliferation Kit (Promocell). Following
stimulation with LPS and/or adiponectin for 24 h and 48 h, cells
were incubated with XTT reaction solution for 4 h. Finally, the
absorbance was measured by using a microplate reader at
490 nm.
In-vitro wound healing assay
In order to study the wound fill rate in vitro, we used an
established in-vitro wound healing model [34,35]. Briefly,
epithelial cells were seeded onto 35 mm culture dishes (Greiner
Bio-One, Frickenhausen, Germany) and grown until confluence.
Then, defined cell-free areas were created by disrupting the
monolayers with sterile instruments in a standardized manner.
Subsequently, medium was changed and cells were stimulated, as
described above. Pictures of the wounded area were taken on an
inverted microscope (Axiovert 25 C, AxioCam, Zeiss, Oberko-
chen, Germany) immediately after wounding and at 1 d, 2 d and
3 d. The wound areas were then measured and analyzed with the
freely available image-processing software ImageJ 1.43 (http://
rsb.info.nih.gov/ij). In order to determine the percentage of
wound fill, the recovered wound areas at 1 d, 2 d, and 3 d were
related to the wound areas measured at baseline.
Immunohistochemistry
Gingival tissues were derived from patients who underwent
wisdom tooth extraction in the Dept. of Oromaxillofacial Surgery
of the University of Bonn. The tissue samples were fixed in 4%
buffered formalin (Sigma-Aldrich) and embedded in paraffin. In
order to assess the presence of adiponectin, 4 mm thick tissue
slices were prepared and immunostaining for adiponectin in the
epithelial and subepithelial layers of the gingiva was performed.
Briefly, selected sections were deparaffinized, rehydrated and
rinsed with tris-buffered saline (TBS, Sigma-Aldrich) for 10 min.
Endogenous peroxidase was blocked in a methanol/H2O2
(Merck, Darmstadt, Germany) solution in the dark for 45 min.
Sections were blocked with 1% bovine serum albumin (BSA,
Sigma-Aldrich) at room temperature (RT) for 20 min and
incubated with rabbit anti-adiponectin (Santa Cruz Biotechnol-
ogy, Heidelberg, Germany) in a 1:50 dilution in a humid
chamber overnight. Antigen–antibody binding was visualized
using the EnVision Detection System Peroxidase/DAB (Dako,
Hamburg, Germany) and slides were counterstained with
Mayer’s haematoxylin.
Immunofluorescence
Oral epithelial cells were grown on coverslips and cultured for
24 h. Cells were fixed in 4% paraformaldehyde (Sigma-Aldrich)
for 15 min, washed in PBS and treated with PBS containing
0.1% Triton X-100 (Sigma-Aldrich) for 15 min. Then, cells were
washed, blocked with 10% BSA for 1 h at RT and incubated
with a rabbit anti-adiponectin antibody (Santa Cruz Biotechnol-
ogy) in a 1:75 dilution. After washing, cells were incubated with a
Cy3-conjugated goat anti-rabbit IgG secondary antibody (1:500;
Dianova, Hamburg, Germany) at RT for 1 h. For nuclear
Table 1. Sequences, efficiency and annealing temperature of primers.
Gene Primer sequences Efficiency Annealing temperature
Adiponectin sense
antisense
59-GCCTCTTCAAGAAGGACAAGGCTATG -39
59-CAGTTGGTGTCATGGTAGAGAAG -39
1.93 69uC
AdipoR1 sense
antisense
59-ACTGGAGCTGGCCTTTATGCTGC -39
59-AGAGAAGGGTGTCATCAGTACAGC -39
2.04 69uC
AdipoR2 sense
antisense
59-CCATAGGGCAGATAGGCTGGTTGA -39
59-CAGTGCATCCTCTTCACTGCAGC -39
1.97 69uC
b-actin sense
antisense
59-CATGGATGATGATATCGCCGCG-39
59-ACATGATCTGGGTCATCTTCTCG-39
1.84 69uC
HMOX1 sense
antisense
59-CCAGGCAGAGAATGCTGAGTTCAT-39
59-CCGTACCAGAAGGCCAGGTCC-39
1.97 69uC
IL1b sense
antisense
59-ATGGCAGAAGTACCTGAGCTCGC-39
59-TTAGGAAGACACAAATTGCATGGTG-39
1.83 68uC
IL6 sense
antisense
59-ATGAACTCCTTCTCCACAAGC-39
59-CTACATTTGCCGAAGAGCCC-39
2.12 68uC
IL8 sense
antisense
59-ATGACTTCCAAGCTGGCCGTGG-39
59-TGAATTCTCAGCCCTCTTCAAAAAC-39
2.02 68uC
IL10 sense
antisense
59-TTAAGGGTTACCTGGGTTGC-39
59-GCCTTGCTCTTGTTTTCACA-39
1.94 65uC
MMP1 sense
antisense
59-ATGCACAGCTTTCCTCCACTGC-39
59-CACTGGGCCACTATTTCTCCGC-39
2.05 69uC
MMP3 sense
antisense
59-ATCGATGCAGCCATTTCTGATAAGG-39
59-TCAACAATTAAGCCAGCTGTTACT-39
2.06 69uC
Involucrin sense
antisense
59-CCCAGCAACACACACTGCCAGT-39
59-GCTCAGGCAGTCCCTTTACAGCA-39
1.98 69uC
TGFb1 sense
antisense
59-GAGCCCTGGACACCAACTAT-39
59-GACCTTGCTGTACTGCGTGT-39
1.94 69uC
KGF sense
antisense
59-AGTTGGAATTGTGGCAATCA-39
59-CCGTTGTGTGTCCATTTAGC-39
1.84 65uC
doi:10.1371/journal.pone.0030716.t001
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were washed and mounted with Mowiol/DABCO (Roth,
Karlsruhe, Germany) for fluorescence microscopic analysis. Cells
treated with LPS and/or adiponectin for 2 h were processed in
the same manner, except incubation with a rabbit anti-NFkB
(p65) antibody (1:100; BioLegend GmbH, Fell, Germany). For
quantification, all nuclei were counted in five fields of vision at a
primary magnification of 406.N F kB positive nuclei were plotted
as percentage of all nuclei.
Statistical Analysis
Mean 6 SEM (n=6) were calculated. One-way ANOVA and
the post-hoc Tukey’s multiple comparison test were applied using
a statistical software program (GraphPad Software, San Diego,
CA, USA). P-values less than 0.05 were considered to be
statistically significant.
Results
Presence of adiponectin in oral epithelial cells
Healthy human gingival tissue sections showed a strong
adiponectin synthesis in oral epithelial cells, as analyzed by
immunohistochemistry. By contrast, only weak staining was found
in the subepithelial layer (Fig. 1A and B). The presence of
adiponectin in oral epithelium was also confirmed at transcrip-
tional and protein levels in cultured oral epithelial cells, as shown
in Fig. 1C–F. Furthermore, oral epithelial cells expressed both
receptors for adiponectin (Fig. 1E and F). Taken together, these
findings suggest that epithelial cells are a significant source and
target of adiponectin in gingival tissues.
Actions of adiponectin on pro- and anti-inflammatory
mediators in oral epithelial cells
Adiponectin down-regulated significantly the constitutive
mRNA expression of IL1b at 4 h and 24 h, as analyzed by
real-time PCR (Fig. 2A). Moreover, adiponectin inhibited
significantly the mRNA expression of IL6 at 24 h and of IL8 at
4 h (Fig. 2A). Interestingly, anti-inflammatory mediators were
also subject to regulation by adiponectin: After an initial
adiponectin-induced down-regulation of IL10 mRNA at 4 h
and 8 h, the levels of this anti-inflammatory molecule were
significantly increased at 24 h. In addition, the HMOX1
expression was significantly enhanced by adiponectin at 4 h
and 8 h (Fig. 2B). In summary, these data suggest that
adiponectin regulates the expression of pro- and anti-inflamma-
tory mediators in oral epithelial cells.
Effect of adiponectin on the LPS-stimulated nuclear
translocation of NFkB
As shown in Fig. 3A and B, LPS from P. gingivalis induced a
pronounced nuclear translocation of NFkB at 2 h, whereas no
such effect was observed for adiponectin. Interestingly, adiponec-
tin abolished the LPS-stimulated NFkB translocation, as visualized
by immunofluorescence (Fig. 3A and B).
Effects of adiponectin on the LPS-induced expression of
pro- and anti-inflammatory cytokines
LPS caused a significant up-regulation of the IL1b mRNA
expression at 4 h and 8 h but had no stimulatory effect on this
cytokine at 24 h (Fig. 4A). Interestingly, adiponectin significantly
Figure 1. Adiponectin in gingival tissues and cultured oral epithelial cells. (A) Representative gingival tissue section from one out of 6
patients exhibiting adiponectin distribution assessed by immunohistochemistry with DAB-staining (brown color). (B) Higher magnification of the
rectangular area shown in (A). (C) Immunofluorescence staining of adiponectin in cultured oral epithelial cells from one out of 6 patients. (D) Higher
magnification of the rectangular area shown in (C). (E) Gene expression of adiponectin and its receptors AdipoR1 and AdipoR2 from oral epithelial
cells of 2 patients (P1 and P2), as demonstrated by gel electrophoresis. (F) Gene expression of adiponectin and its receptors AdipoR1 and AdipoR2
from oral epithelial cells from 6 patients, as demonstrated by real-time PCR.
doi:10.1371/journal.pone.0030716.g001
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and also led to a significant decrease in the constitutive IL1b
expression at 4 h and 24 h (Fig. 4A). Similar findings were
observed at protein level at 24 h, as determined in the
supernatants by ELISA (Fig. 4B). Furthermore, LPS significantly
increased the IL6 mRNA expression at 4 h, 8 h, and 24 h. As
observed for IL1b, IL6 was significantly down-regulated by
adiponectin in LPS-stimulated cells (Fig. 4C). Although adipo-
nectin did not affect the constitutive IL6 mRNA expression at 4 h
and 8 h, this adipokine caused a significant reduction of the
constitutive IL6 expression at 24 h (Fig. 4C). The chemokine IL8
was also significantly up-regulated by LPS at 8 h and 24 h
(Fig. 4D). The LPS-induced IL8 mRNA expression was signifi-
cantly reduced by adiponectin at 8 h and 24 h. Additionally, the
constitutive mRNA expression of IL8 was down-regulated by
adiponectin at 4 h (Fig. 4D). The transcriptional data on IL8 were
paralleled by findings at protein level (Fig. 4E). LPS also up-
regulated significantly the mRNA expression of the anti-inflam-
matory cytokine IL10 at 8 h (Fig. 4F). However, adiponectin
abrogated the stimulatory effects of LPS on IL10 expression at this
time point. Moreover, adiponectin inhibited significantly the
constitutive IL10 expression at 4 h and stimulated significantly the
constitutive expression of IL10 mRNA at 24 h (Fig. 4F). In
summary, these results suggest that adiponectin may dampen
inflammatory processes in periodontitis by regulation of pro- and
anti-inflammatory cytokines.
Effects of adiponectin on the LPS-induced up-regulation
of MMPs
LPS also affected the production of the matrix-degrading
proteases MMP1 and MMP3 in epithelial cells (Fig. 5A–C). In the
presence of LPS, MMP1 and MMP3 were significantly up-
regulated at 8 h and 24 h and at 4 h, 8 h, and 24 h, respectively
(Fig. 5A and C). At all time points, adiponectin diminished
significantly the LPS-induced mRNA expression of MMP1 and
MMP3 (Fig. 5A and C). The stimulatory effect of LPS on MMP1
and the inhibition of the LPS action by adiponectin were also
observed at protein level (Fig. 5B). Our data suggest that
adiponectin exerts matrix-protective effects by down-regulation
of MMPs.
Figure 2. Effects of adiponectin on pro- and anti-inflammatory mediators. Effects of adiponectin (1 mg/ml) on IL1b, IL6 and IL8 (A) as well as
IL10 and HMOX1 (B) in oral epithelial cells at 4 h, 8 h, and 24 h. Mean 6 SEM; n=6; * p,0.05 difference between adiponectin-treated and control
cells.
doi:10.1371/journal.pone.0030716.g002
Figure 3. Effect of lipopolysaccharide and/or adiponectin on NFkB signaling. Effect of lipopolysaccharide (LPS; 2 mg/ml) and/or adiponectin
(Adipo; 1 mg/ml) on the nuclear translocation of NFkB at 2 h. NFkB visualized by immunofluorescence (A). Quantitative analysis of
immunofluorescence samples; evaluation as % NFkB positive nuclei (B).
doi:10.1371/journal.pone.0030716.g003
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viability and wound fill rate
Although the epithelial cell proliferation was not strongly
affected by LPS and/or adiponectin, the stimulatory effect of LPS
was significant at 24 h (Fig. 6A). Interestingly, the LPS-induced
increase in epithelial cell proliferation was significantly counter-
regulated by adiponectin at this time point. These findings suggest
that adiponectin may inhibit the formation of pocket epithelium in
the presence of periodontal infection. Furthermore, our experi-
ments revealed, that LPS significantly reduced the percentage of
viable cells over a time period of 72 h and that the LPS-induced
decrease in cell viability was significantly abolished in the presence
of adiponectin (Table 2), indicating that adiponectin may protect
against infection-induced damage of epithelial cells and, thereby,
increased permeability of the epithelial barrier. Next we studied
whether LPS and/or adiponectin modulated the wound closure in
an in-vitro wound healing assay over 3 days. The wound closure in
cell cultures treated either with LPS or adiponectin alone was not
significantly different from that of control cells. However, when
cells were simultaneously exposed to LPS and adiponectin, the
wound closure was significantly delayed as compared to control
(Fig. 6B). These findings suggest that adiponectin, when combined
with LPS from P. gingivalis, may inhibit the wound fill rate in LPS-
treated epithelial cells.
Inhibition of the LPS-induced involucrin expression by
adiponectin
LPS increased significantly the involucrin mRNA expression in
epithelial cells at 4 h and 8 h. An LPS-induced up-regulation of
involucrin was also observed at 24 h but the increase did not reach
significance (Table 3). When LPS-treated cells were exposed to
adiponectin, the involucrin mRNA expression was significantly
reduced (Table 3). These data suggest that adiponectin may inhibit
the formation of a pocket epithelium by both inhibition of the
Figure 4. Interactions of lipopolysaccharide and adiponectin on pro- and anti-inflammatory mediators. Effects of lipopolysaccharide
(LPS; 2 mg/ml) and/or adiponectin (Adipo; 1 mg/ml) on the mRNA expression of IL1b (A), IL6 (C), IL8 (D), and IL10 (F) at 4 h, 8 h, and 24 h and on the
protein level of IL1b (B) and IL8 (E) in supernatants at 24 h and 72 h. Mean 6 SEM; n=6; * p,0.05 difference between groups.
doi:10.1371/journal.pone.0030716.g004
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epithelial differentiation.
Regulation of TGFb1 and KGF by adiponectin and/or LPS
Although the constitutive TGFb1 expression was not signifi-
cantly regulated by LPS, adiponectin caused a significant TGFb1
down-regulation at 4 h and 24 h (Table 3). Adiponectin did not
significantly affect TGFb1 levels in LPS-treated cells (Table 3).
Furthermore, LPS significantly up-regulated KGF at 8 h and
significantly down-regulated this growth factor at 24 h. Although
adiponectin abolished the LPS-increased KGF expression at 8 h,
this adipokine had no significant influence on the LPS-down-
regulated KGF expression at 24 h. In addition, adiponectin
decreased significantly the constitutive KGF mRNA expression at
4 h and 8 h in epithelial cells. In summary, these data suggest that
adiponectin may exert inhibitory effects on KGF expression and,
therefore, formation of pocket epithelium.
Discussion
Our experiments demonstrated that LPS from P. gingivalis,
which is considered one of the main etiological agents of
periodontal diseases, elicits synthesis of pro-inflammatory cyto-
kines and matrix-degrading enzymes and promotes proliferation
and differentiation of oral epithelial cells, emphasizing the
pathogenic role of this microorganism in periodontal inflamma-
tion, destruction and pocket formation. However, more impor-
tantly, our study shows that the LPS-induced effects on oral
epithelial cells are counteracted by adiponectin, which is a novel
finding and might, at least partially, explain how overweight and
obesity can increase the risk of periodontitis.
LPS, which is a major macromolecule on the outer surface of P.
gingivalis, has been shown to bind to TLR2 and TLR4 [8,10].
Upon receptor engagement, LPS triggers an intracellular signaling
cascade, which involves the nuclear transactivation of NFkB [8].
The gingival epithelium is the first physical barrier, which
periodontopathogenic bacteria, such as P. gingivalis, encounter [6].
Our experiments revealed that P. gingivalis-LPS induces the
expression and release of pro-inflammatory cytokines in oral
epithelial cells, which underlines the detrimental role of this
pathogen in periodontal diseases. These findings are in line with
several other in-vitro studies, which have also demonstrated a
stimulatory effect of P. gingivalis-LPS on the synthesis of these
inflammatory mediators in oral epithelial cells [11,13,36]. In one
of these studies, it was also analyzed whether LPS from P. gingivalis
induces the release of proteases [36]. P. gingivalis-LPS did not affect
the secretion of MMP2 and MMP9 in oral epithelial cells. Since
MMP1 and MMP3 have also been implicated in periodontal
destruction, we studied their expression in oral epithelial cells in
response to P. gingivalis [37–39]. Interestingly, both MMPs were
up-regulated by LPS, suggesting that LPS from P. gingivalis can
promote periodontal destruction via stimulation of both inflam-
mation and matrix-degradation. In one study, oral epithelial cells
were exposed to P. gingivalis-derived membrane vesicles, which
retain the full components of the outer membrane constituents,
including LPS [12]. The expression of IL6, IL8, MMP1, and
MMP3 were significantly up-regulated in the vesicle-stimulated
cells, which is in accordance with our data for LPS. The most
important and novel finding of our study is that the pro-
inflammatory and matrix-degrading effects of LPS on oral
epithelial cells were significantly reduced in the presence of
adiponectin. This observation is in accordance with several studies
on monocytes and macrophages [25,32,40]. However, period-
ontopathogens, such as P. gingivalis, will usually first encounter oral
epithelial cells, which are present in the gingiva in great numbers.
Therefore, our finding, that the protective actions of adiponectin
are not limited to immunoinflammatory cells in the gingiva, might
be of utmost importance.
A few studies have suggested that adiponectin also exerts pro-
inflammatory and tissue-destructive effects [41,42]. It has even
been speculated that an initial up-regulation of pro-inflammatory
mediators by adiponectin might also be the cause for the
subsequent anti-inflammatory effects of this adipokine [43,44].
Moreover, this initial pro-inflammatory effect might result from
contamination of adiponectin with LPS during the manufacture
process [45]. Interestingly, such an initial adiponectin-induced
increase of pro-inflammatory cytokines was not observed in our
Figure 5. Interactions of lipopolysaccharide and adiponectin
on matrix metalloproteinases. Effects of lipopolysaccharide (LPS;
2 mg/ml) and/or adiponectin (Adipo; 1 mg/ml) on the mRNA expression
of MMP1 (A) and MMP3 (C) at 4 h, 8 h, and 24 h and on the protein
level of MMP1 (B) in supernatants at 24 h and 72 h. Mean 6 SEM; n=6;
*p ,0.05 difference between groups.
doi:10.1371/journal.pone.0030716.g005
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anti-inflammatory effects of adiponectin [25,40,43]. In the present
study, we did not perform blocking experiments for IL10.
However, the pro-inflammatory cytokines were already down-
regulated by adiponectin at 4 h, when the IL10 expression was not
yet increased by LPS and/or adiponectin, indicating that IL10
may not play a role in the anti-inflammatory actions of
adiponectin at this early time point. Whether adiponectin mediates
anti-inflammatory effects via up-regulation of IL10 at later time
points, as observed at 24 h, needs to be further determined.
Recently, HMOX1 has been identified as another important
downstream mediator for the anti-inflammatory actions of
adiponectin in primary cultures of Kupffer cells [25]. Interestingly,
HMOX1 was significantly up-regulated by adiponectin in oral
epithelial cells, suggesting that HMOX1 might be responsible, at
least in part, for the anti-inflammatory effects of adiponectin in our
study. Finally, adiponectin might interfere with the binding of LPS
to its receptor because of the high binding affinity of adiponectin
to LPS, suggesting an additional extracellular mode of anti-
inflammatory action for adiponectin [46]. If this mechanism also
contributed to the anti-inflammatory effects of adiponectin in our
experiments remains to be elucidated.
In the circulation, adiponectin occurs as full-length and globular
adiponectin. Full-length adiponectin exists as low, middle and high
molecular weight oligomeric complexes. In addition, full-length
adiponectin can be proteolytically cleaved to globular adiponectin,
which consists of the C-terminal domain of the full-length protein.
Both forms of adiponectin are biologically active and bind to the
adiponectin receptors. Upon receptor engagement, adiponectin
triggers several intracellular signaling pathways [23,47,48].
Different forms of adiponectin have been used in in-vitro studies,
and although these forms often have similar effects, some actions
are different, which could also explain controversial results among
studies [47]. As mentioned above, LPS triggers an intracellular
signaling cascade, which involves the nuclear translocation of
NFkB [8]. Our experiments revealed that adiponectin inhibits the
LPS-induced NFkB nuclear translocation in oral epithelial cells.
This observation concurs with findings in other cells, where
adiponectin inhibited the LPS-stimulated IkB degradation, thus
preventing NFkB activation and DNA binding activity of NFkB
[49–52]. Whether adiponectin also affects other LPS-triggered
signaling pathways, such as ERK1/2, as it has been suggested,
needs to be determined in further studies [52,53].
Since epithelial cell migration, proliferation, and differentiation
are critical to periodontal pocket formation in periodontitis, we
Figure 6. Interactions of lipopolysaccharide and adiponectin on proliferation and wound closure. Effects of lipopolysaccharide (LPS;
2 mg/ml) and/or adiponectin (Adipo; 1 mg/ml) on the proliferation at 24 h and 48 h (A) and wound closure over 72 h (B). Mean 6 SEM; * p,0.05
difference between groups (A) and difference between cells simultaneously treated with LPS and adiponectin, and control (A).
doi:10.1371/journal.pone.0030716.g006
Table 2. Interactions of lipopolysaccharide and adiponectin
on cell viability.
Cell viability (%)
Group 24 h 48 h 72 h
Control 93.3060.96 95.6360.58 96.7960.64
LPS 79.2562.80* 84.0360.47* 80.4960.90*
Adipo 99.8161.02*
{ 99.7360.32*
{ 99.7860.77
{
LPS + Adipo 95.2260.36
{ 90.9760.30*
{ # 96.0660.11
{ #
Effects of lipopolysaccharide (LPS; 2 mg/ml) and/or adiponectin (Adipo; 1 mg/ml)
on the cell viability, as assessed by trypan blue exclusion test, at 24 h, 48 h, and
72 h. Mean 6 SEM; n=6;
*p,0.05 different from control,
{different from LPS-treated cells,
#different from adiponectin-treated cells.
doi:10.1371/journal.pone.0030716.t002
Table 3. Interactions of lipopolysaccharide and adiponectin
on involucrin and growth factors.
Target
gene Group 4 h 8 h 24 h
Involucrin LPS 2.9160.12* 4.8660.34* 1.5860.24
Adipo 0.8760.13
{ 2.5060.21*
{ 0.9760.23
LPS + Adipo 0.8960.21
{ 2.0260.14*
{ 0.6960.10
{
TGFb1 LPS 1.0660.07 0.7760.07 0.8360.19
Adipo 0.2860.04*
{ 1.0360.06 0.5260.09*
LPS + Adipo 0.9660.14
# 0.7560.04*
# 0.8460.05
KGF LPS 0.6360.16 2.0160.11* 0.5960.03*
Adipo 0.1960.04*
{ 0.6460.06*
{ 1.0260.10
{
LPS + Adipo 0.4960.09* 0.6860.08
{ 0.4160.05*
#
Effects of lipopolysaccharide (LPS; 2 mg/ml) and/or adiponectin (Adipo; 1 mg/ml)
on the mRNA expression of involucrin, TGFb1, and KGF at 4 h, 8 h, and 24 h
expressed as fold of control. Mean 6 SEM; n=6;
*p,0.05 different from control,
{different from LPS-treated cells,
#different from adiponectin-treated cells.
doi:10.1371/journal.pone.0030716.t003
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parameters [1]. In an in-vitro wound healing assay, which mainly
assesses cell migration and proliferation, adiponectin alone had no
significant effect on epithelial cells. However, when these cells were
exposed to adiponectin in the presence of LPS, the wound closure
was significantly delayed, suggesting that adiponectin may inhibit
cell migration in the presence of periodontal infection. At 1 day,
adiponectin also inhibited the proliferation of oral epithelial cells
exposed to LPS, suggesting that adiponectin may have, at least
initially, some anti-proliferative effects in the presence of
periodontal infection. Interestingly, adiponectin also reduced the
LPS-induced cell proliferation and migration in a study on
adventitial fibroblasts, supporting our results in oral epithelial cells
[54]. The cell viability was significantly reduced by LPS but the
LPS-induced decrease in cell viability was abrogated by adipo-
nectin, indicating that adiponectin may protect against infection-
induced damage of epithelial cells. However, another study did not
observe P. gingivalis-induced changes in oral epithelial cell viability
and numbers, but the controversial results could be explained by
the different sources, strains and/or concentrations of LPS [11]. In
studies on cancer cells, it has been shown that the anti-proliferative
effect of adiponectin involves inhibition of cell cycle and activation
of cell apoptosis [27,55]. Whether P. gingivalis-LPS and adiponectin
also affect apoptosis of oral epithelial cells remains to be examined
in further studies. The epithelium acts as a protective barrier
against physical, chemical, and microbial insults. In order to fulfill
this function, epithelial cells undergo differentiation and express a
number of structural proteins, such as involucrin [28–30]. Our
experiments revealed that LPS from P. gingivalis up-regulates
involucrin, whereas adiponectin counteracts the stimulatory effects
of LPS on this differentiation marker, suggesting that adiponectin
may prevent epithelial cell differentiation and, thereby, formation
of pocket epithelium, in the presence of periodontal infection.
Since epithelial proliferation and migration are regulated by
growth factors, we also studied the expression of KGF1 and
TGFb1 in oral epithelial cells. KGF1 belongs to the heparin-
binding fibroblast growth factor family, binds to the epithelial-
specific KGF receptor and stimulates epithelial cell proliferation
and migration [56–58]. Moreover, KGF1 has been shown to
inhibit tumor necrosis factor-a- and LPS-induced epithelial cell
apoptosis [59]. Although KGF is usually expressed by connective
tissues, this growth factor has also been detected in epithelial cells,
where it seems to act in an autocrine manner [60,61]. It has been
hypothesized that the KGF1 up-regulation in periodontal diseases
is associated with the onset and progression of periodontal pocket
formation. The increased KGF1 protein production in epithelial
cells may reduce apoptosis and maintain the integrity of the
epithelium despite bacterial infection [62]. Although epithelial cell
proliferation is a hallmark of periodontitis, the regulation of this
proliferation is only partially unraveled. Our experiments revealed
that LPS from P. gingivalis transiently up-regulated KGF at 8 h and
decreased the KGF expression at 24 h. More importantly,
adiponectin down-regulated significantly the constitutive KGF
expression at 4 h and 8 h and also inhibited significantly the LPS-
induced KGF expression at 8 h. Thus, the anti-proliferative effect
of adiponectin in the presence of LPS may be, at least in part,
mediated by inhibition of the KGF expression. TGFb1 is another
important growth factor, which regulates cell proliferation and
migration, matrix synthesis, angiogenesis, and wound healing
processes. TGFb1 has both pro-inflammatory and immunosup-
pressive effects [63]. Increased TGFb1 concentrations in gingival
tissues and GCF from sites with deeper periodontal pockets have
been reported [64]. In the present study, LPS had no effect on
TGFb1, and the addition of adiponectin to LPS-stimulated cells
caused only minor changes in TGFb1 expression. Thus, the anti-
proliferative effects of adiponectin on LPS-treated cells do not
seem to be dependent on TGFb1.
In summary, our experiments demonstrated that adiponectin
abrogates the P. gingivalis-LPS-induced up-regulation of pro-
inflammatory cytokines and matrix-degrading enzymes as well as
proliferation and differentiation of oral epithelial cells. Therefore,
low levels of adiponectin, as observed in overweight and obese
individuals, may confer an increased risk for periodontal
inflammation, destruction and pocket formation.
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